Cerus Corporation (CERS): Price and Financial Metrics

Cerus Corporation (CERS): $1.71

0.06 (+3.64%)

POWR Rating

Component Grades








Add CERS to Watchlist
Sign Up

Industry: Biotech




#91 of 347

in industry

CERS Price/Volume Stats

Current price $1.71 52-week high $4.25
Prev. close $1.65 52-week low $1.21
Day low $1.59 Volume 1,194,000
Day high $1.71 Avg. volume 1,330,257
50-day MA $1.52 Dividend yield N/A
200-day MA $2.13 Market Cap 309.85M

CERS Stock Price Chart Interactive Chart >


  • CERS scores best on the Growth dimension, with a Growth rank ahead of 94.49% of US stocks.
  • CERS's strongest trending metric is Quality; it's been moving down over the last 177 days.
  • CERS ranks lowest in Momentum; there it ranks in the 10th percentile.

CERS Stock Summary

  • CERUS CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 86.52% of US listed stocks.
  • Over the past twelve months, CERS has reported earnings growth of 27.36%, putting it ahead of 74.43% of US stocks in our set.
  • The volatility of CERUS CORP's share price is greater than that of 80.81% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CERUS CORP are LCTX, APLS, OMIC, TVTX, and FCEL.
  • Visit CERS's SEC page to see the company's official filings. To visit the company's web site, go to www.cerus.com.

CERS Valuation Summary

  • CERS's EV/EBIT ratio is -9.7; this is 176.38% lower than that of the median Healthcare stock.
  • CERS's price/sales ratio has moved down 8.2 over the prior 243 months.

Below are key valuation metrics over time for CERS.

Stock Date P/S P/B P/E EV/EBIT
CERS 2023-11-20 1.8 6.7 -6.5 -9.7
CERS 2023-11-17 1.7 6.6 -6.4 -9.5
CERS 2023-11-16 1.7 6.5 -6.3 -9.4
CERS 2023-11-15 1.7 6.5 -6.3 -9.4
CERS 2023-11-14 1.7 6.6 -6.4 -9.5
CERS 2023-11-13 1.5 5.9 -5.8 -8.7

CERS Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at 13.22%.
  • The 2 year net cashflow from operations growth rate now stands at 41.06%.
  • Its year over year net income to common stockholders growth rate is now at 19.14%.
CERS's revenue has moved up $112,651,000 over the prior 49 months.

The table below shows CERS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 187.082 -25.081 -38.274
2022-06-30 182.84 -29.605 -42.229
2022-03-31 172.972 -37.402 -49.201
2021-12-31 159.518 -33.922 -54.374
2021-09-30 143.02 -41.158 -59.636
2021-06-30 130.11 -39.255 -61.338

CERS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CERS has a Quality Grade of C, ranking ahead of 39.02% of graded US stocks.
  • CERS's asset turnover comes in at 0.647 -- ranking 61st of 186 Medical Equipment stocks.
  • BSGM, NVCR, and STRR are the stocks whose asset turnover ratios are most correlated with CERS.

The table below shows CERS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.647 0.607 -0.310
2021-06-30 0.592 0.619 -0.303
2021-03-31 0.547 0.631 -0.294
2020-12-31 0.528 0.640 -0.286
2020-09-30 0.529 0.643 -0.318
2020-06-30 0.530 0.654 -0.360

CERS Price Target

For more insight on analysts targets of CERS, see our CERS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.00 Average Broker Recommendation 1.2 (Strong Buy)

Cerus Corporation (CERS) Company Bio

Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.

CERS Latest News Stream

Event/Time News Detail
Loading, please wait...

CERS Latest Social Stream

Loading social stream, please wait...

View Full CERS Social Stream

Latest CERS News From Around the Web

Below are the latest news stories about CERUS CORP that investors may wish to consider to help them evaluate CERS as an investment opportunity.

Positive week for Cerus Corporation (NASDAQ:CERS) institutional investors who lost 54% over the past year

Key Insights Significantly high institutional ownership implies Cerus' stock price is sensitive to their trading...

Yahoo | November 6, 2023

Cerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call Transcript

Cerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call Transcript November 2, 2023 Cerus Corporation beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.05. Operator: Good day and thank you for standing by. Welcome to Cerus Corporation Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ […]

Yahoo | November 3, 2023

Cerus Corporation to Participate in Upcoming Investor Conferences

CONCORD, Calif., November 03, 2023--Cerus Corporation (NASDAQ:CERS) announced today that the Company will participate in two upcoming investor conferences:

Yahoo | November 3, 2023

Cerus Corp (CERS) Q3 2023 Earnings: Product Revenue Stable, Operating Expenses Decrease by 4%

Company reaffirms commitment to achieve non-GAAP adjusted EBITDA breakeven in Q4 2023

Yahoo | November 2, 2023

Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates

Cerus (CERS) delivered earnings and revenue surprises of 40% and 2.76%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 2, 2023

Read More 'CERS' Stories Here

CERS Price Returns

1-mo 11.04%
3-mo 4.27%
6-mo -32.68%
1-year -56.60%
3-year -77.08%
5-year -68.97%
YTD -53.15%
2022 -46.40%
2021 -1.59%
2020 63.98%
2019 -16.77%
2018 50.00%

Continue Researching CERS

Want to see what other sources are saying about Cerus Corp's financials and stock price? Try the links below:

Cerus Corp (CERS) Stock Price | Nasdaq
Cerus Corp (CERS) Stock Quote, History and News - Yahoo Finance
Cerus Corp (CERS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!